My prediction here is that for natural and totally understandable reasons, it will be hard to gauge the investability of international companies vs US startups.

So over a period of time, we might see prorata moving to US startups fairly naturally . Given the other issues around travel in a post-COVID world, this will might to a return to US centric portfolio allocation.